XNAS · Healthcare · Drug Manufacturers - Specialty & Generic
Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. It develop, manufacture and market products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. It has three segments Animal Health, Mineral Nutrition, and Performance Products. Majority of revenue comes from Animal Health segment. Animal health products are anti-bacterials, anticoccidials, nutritional specialty products, and vaccines, and vaccine adjuvants that help improve the animal's health.
Phibro delivered a solid beat, with **Q4 EPS of $0.85** topping estimates by $0.13 on **$397M revenue** versus $376M expected. In animal health, that signals improving execution and healthy operating leverage, reinforced by the new $0.12 dividend.
AI-generated summary — powered by BigEarnings.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-26 | Q4 2026 | 0.72 | 0.85 | +18.06% | $396.7M | ✅ Beat | +5.99% | — | — |
| 2026-05-06 | Q3 2026 | 0.71 | 0.76 | +7.04% | $383.5M | ✅ Beat | -10.92% | -39.73% | -44.56% |
| 2026-02-04 |
| Q2 2026 |
| 0.68 |
| 0.87 |
| +27.94% |
| $373.9M |
| ✅ Beat |
| +13.90% |
| +25.66% |
| +16.88% |
| 2025-11-05 | Q1 2026 | 0.60 | 0.73 | +21.67% | $363.9M | ✅ Beat | — | — | — |
| 2025-08-27 | Q4 2025 | 0.52 | 0.57 | +9.62% | $378.7M | ✅ Beat | +17.98% | +18.62% | +20.53% |
| 2024-08-28 | Q4 2024 | 0.33 | 0.41 | +24.24% | $273.2M | ✅ Beat | +3.17% | -5.57% | +6.05% |
| 2024-05-08 | Q3 2024 | 0.29 | 0.31 | +6.90% | $263.2M | ✅ Beat | +3.03% | +6.23% | -0.12% |
| 2024-02-07 | Q2 2024 | 0.28 | 0.33 | +17.86% | $249.9M | ✅ Beat | — | — | — |
Showing last 8 quarters.